Document:

EX-10.42

 Exhibit 10.42 

 
 January 10, 2013 

Robert O. Cathcart 
 5 Hidden Acres Drive 

Kinnelon, NJ. 07405 
 Dear Bob, 

Hansen Medical, Inc. (the “Company”) is pleased to offer you employment on the following terms: 

1. Position: Your title will be Senior Vice President of Global Sales. This position will report to Bruce Barclay, the Company’s President and
Chief Executive Officer, and is a full-time position contingent upon successful completion of reference and background checks. While you render services to the Company, you will not engage in any other employment, consulting or other business
activity (whether full-time or part-time) that would create a conflict of interest with the Company. By signing this letter agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit
you from performing your duties for the Company. 
 2. Cash Compensation: The Company will pay you a starting salary of $240,000 per year, payable in
accordance with the Company’s standard payroll schedule. This salary will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. You will also receive a monthly car allowance of $600,
or $7,200 annually. 
 3. Variable Compensation: Your annual variable compensation is targeted at $265,000 and is summarized in the 2013 Target
Compensation Summary in the form of the document attached hereto as Exhibit A. 
 4. Corporate Incentive Bonus Plan: Subject to the approval
of the Company’s Board of Directors, you will be granted 12,500 Restricted Stock Units under the Company’s 2013 Corporate Incentive Bonus Plan. Vesting of these units is contingent upon performance against Corporate and Department
objectives as determined by the Company’s Board of Directors during the first quarter of 2014. 
 5. Employee Benefits: As a regular employee of
the Company, you will be eligible to participate in a number of Company-sponsored benefits. In addition, you will be entitled to three weeks paid vacation in accordance with the Company’s vacation policy. 

6. Stock Options: Subject to the approval of the Company’s Board of Directors or its Compensation Committee, you will be granted an option to
purchase 300,000 shares of the Company’s Common Stock. The exercise price per share will be equal to the fair market value per share on the date the option is granted. 

 Robert O. Cathcart 

January 10, 2013 
  Page
 2
 
  

 The option will be subject to the terms and conditions applicable to options granted under the Company’s
2006 Equity Incentive Plan (the “Plan”), as described in the Plan and the applicable Stock Option Agreement. You will vest in 25% of the option shares after 12 months of continuous service, and the balance will vest in equal monthly
installments over the next 36 months of continuous service, as described in the applicable Stock Option Agreement. 
 7. Retention Agreement: The
Company will offer you the opportunity to enter into a Retention Agreement in the form of the document attached hereto as Exhibit B. 
 8.
Proprietary Information and Inventions Agreement: Like all Company employees, you will be required, as a condition of your employment with the Company, to sign the Company’s standard Proprietary Information and Inventions Agreement, a
copy of which is attached hereto as Exhibit C. 
 9. Employment Relationship: Employment with the Company is for no specific period of time.
Your employment with the Company will be “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations that may have been made to you are
superseded by this letter agreement. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may
change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company (other than you). 

10. Taxes: All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and payroll taxes
and other deductions required by law. You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or its Board of Directors
related to tax liabilities arising from your compensation. 
 11. Interpretation, Amendment and Enforcement: This letter agreement and Exhibits A and
B constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (whether written, oral or implied) between you and
the Company. This letter agreement may not be amended or modified, except by an express written agreement signed by both you and a duly authorized officer of the Company. The terms of this letter agreement and the resolution of any disputes as to
the meaning, effect, performance or validity of this letter agreement or arising out of, related to, or in any way connected with, this letter agreement, your employment with the Company or any other relationship between you and the Company (the
“Disputes”) will be governed by California law, excluding laws relating to conflicts or choice of law. You and the Company submit to the exclusive personal jurisdiction of the federal and state courts located in Santa Clara County,
California, in connection with any Dispute or any claim related to any Dispute. 

 Robert O. Cathcart 

January 10, 2013 
  Page
 3
 
  

 * * * * * 

Bob, we are excited about the possibility of you joining our Company. You may indicate your agreement with these terms and accept this offer
by signing and dating both the enclosed duplicate original of this letter agreement, the 2013 Target Compensation Summary, the Retention Agreement, and the enclosed Proprietary Information and Inventions Agreement and returning them to me. This
offer, if not accepted, will expire at the close of business on January 14, 2013. As required by law, your employment with the Company is contingent upon your providing legal proof of your identity and authorization to work in the United
States, Your employment is also contingent upon your starting work with the Company on or before January 16, 2013. 
 If you have any questions, please
call me at 650-404-5804. 
  

			
	Very truly yours,
	
	HANSEN MEDICAL, INC.
	
	

	By:	 	Bruce J Barclay
		
	Title:	 	President and CEO
	
	I have read and accept this employment offer:
	
	 

	Robert O. Cathcart
		
	Dated:	 	 1/12/2013

 Attachments 
 Exhibit A:
2013 Target Compensation Summary 
 Exhibit B: Retention Agreement 

Exhibit C: Proprietary Information and Inventions Agreement 

 2013 Target Compensation Plan 

Hansen Medical – Senior Vice President, Global Sales (Total Comp) 

Name: Bob Cathcart 
  

													
	 	  	Amount	 	 	Est Achievement	 	  	Annual Estimate	 
	 Systems Revenue- U.S.
	  	$	20,000,000	  	 				  			
	 Systems Revenue- EMEA/AP/ANZ
	  	$	8,788,000	  	 				  			
	 Base Salary
	  	$	240,000	  	 	 	1	  	  	$	240,000	  
	 Commission on Systems Sales at Plan
	  	 	0.75	% 	 	 	1	  	  	$	215,910	  
	 Commission on Systems Revenue > Plan
	  	 	1.50	% 	 	 	0	  	  	$	0	  
	 Quarterly Catheter Bonus
	  	$	6,250	  	 	 	4	  	  	$	25,000	  
	 Quarterly Procedure Bonus
	  	$	6,250	  	 	 	4	  	  	$	25,000	  
	 Car Allowance
	  	$	7,200	  	 	 	1	  	  	$	7,200	  
	 2013 Corporate Bonus Plan (note 1)
	  	$	26,000	  	 	 	1	  	  	$	26,000	  
	 New Hire Options (note 2)
	  	$	420,000	  	 	 	1	  	  	$	420,000	  
	 Total Target Comp.
	   
	  	$	959,110	  

 Commission on systems is paid at a rate of 0.75% on plan revenue and at a rate of 1.5 % on revenue over plan. Plan
revenue is defined as all systems, and new service contracts which are both booked and shipped in the month within the defined territory. Revenue on CoHesion upgrades is added to base revenue and commission is paid at a rate of .5%. Discretionary
discounts, educational grants, rebates, and free trainings reduce the amount used to calculate total base revenue. Commissions are paid on a monthly basis on a one month lag. In addition, any systems booked and shipped before June 30, 2013 will
earn an extra 0.5% commission payment. 
 You will be eligible to participate in Procedure, Catheter bonuses for 2013. Procedure and Catheter bonuses are
targeted at a total of $6,250 per quarter based upon procedure and catheter goals set forth mutually by the CEO and you each quarter by the 15th day of the first month of the quarter. The actual
payout is based upon the percentage of procedures performed and catheters sold in relation to the target based on the table below. Procedure and Catheter bonuses are paid out on a quarterly basis with a one month lag. Actual percent to goal will be
rounded to the nearest whole percent for payout calculation. 
  

													
	 Percent to Goal
	  	% Payout	 	 	Procedure Payout	 	  	Catheter Payout	 
	 0%-79%
	  	 	0	% 	 	$	—  	  	  	$	—  	  
	 80%-89%
	  	 	0	% 	 	$	—  	  	  	$	—  	  
	 90-94%
	  	 	60	% 	 	$	3,750	  	  	$	3,750	  
	 95%-99%
	  	 	75	% 	 	$	4,688	  	  	$	4,688	  
	 100%-109%
	  	 	100	% 	 	$	6,250	  	  	$	6,250	  
	 110% and beyond
	  	 	115	% 	 	$	7,188	  	  	$	7,188	  

  

																					
	Objectives	  	Q1	 	  	Q2	 	  	Q3	 	  	Q4	 	  	Total	 
	 Global Procedure Target
	  	 	864	  	  	 	938	  	  	 	913	  	  	 	1,077	  	  	 	3,792	  
	 Global Catheter Target
	  	 	960	  	  	 	1,043	  	  	 	1,015	  	  	 	1,197	  	  	 	4,215	  

 You must be employed at time of payout to receive any commission and bonus payments. Payout will occur on the last of the
month following each month or quarter of earned commissions. The CEO and Compensation Committee of the Board of Directors reserves the right to make adjustments to the objectives and compensation plan within its sole discretion. 

 Note (1) You will be eligible to participate in the 2013 Corporate Bonus Plan. Payment of this bonus is made
in the form restricted stock units (RSU’s). Subject to the approval of Hansen’s Board of Directors or its Compensation Committee, you will be granted 12,500 RSU’s on or before March 18, 2013. RSU’s granted under this plan
have an assumed value of $2.08 per share. The actual vesting of these shares will be based on performance against Department and Company milestones as determined by Management and the Board of Directors during the first quarter of 2014. 

Note (2) Subject to and following approval by the Board of Directors, the Company will grant you an option to purchase 300,000 shares of the
Company’s common stock at the fair market value as determined by the Board as of the date of grant (the “Option”). The Option will be subject to the terms and conditions of the Company’s Stock Plan (the “Plan”) and your
grant agreement. Your grant agreement will include a four year vesting schedule, under which 25% of your. Option will vest after 12 months and l/48th of the total will vest at the end of each month thereafter, until either the Option is fully vested
or your employment ends, whichever occurs first. For purposes of your 2013 target compensation, these options are valued at $420,000 using a Black-Scholes value of $1.40 per share and assuming an exercise price of $2.15 per share. 

 

					
	

	 		 	

	  
	 		 	  

	Bob Cathcart	 		 	Bruce J Barclay, President & CEO
	1/12/2013	 		 	1-11-13

 RETENTION AGREEMENT 

This Retention Agreement (the “Agreement”) is entered into as of January 10, 2013 by and between Robert O. Cathcart and
Hansen Medical, Inc. (the “Corporation”). 
 AGREEMENT 

In consideration of the promises and mutual covenants set forth herein, the parties hereby agree as follows: 

1. Definitions. As used in this Agreement, unless the context requires a different meaning, the following terms shall have the meanings
set forth herein: 
 (a) “Board” shall mean the Board of Directors of the Corporation 

(b) “Cause” shall mean any of the following: (i) an intentional unauthorized use or disclosure of the Corporation’s
confidential information or trade secrets, which use or disclosure causes material harm to the Corporation, (ii) a material breach of any agreement between Executive and the Corporation, (iii) a material failure to comply with the
Corporation’s written policies or rules, (iv) conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof, (v) gross negligence or willful misconduct or
(vi) a continued failure to perform assigned duties after receiving written notification of such failure from the Board. Executive shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to
Executive a Notice of Termination and copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of those members of the Board who are not then employees of the Corporation at a meeting of the Board called and held for
the purpose (after reasonable notice to Executive and an opportunity for Executive, together with Executive’s counsel, to be heard before the Board), finding that, in the good faith opinion of the Board, Executive was guilty of the conduct set
forth in the first sentence of this Section 1(b) and specifying the particulars thereof in detail. 
 (c) “Change in
Control” means the occurrence of any of the following events: 
 (i) a transaction or series of transactions (other than an
offering of the Corporation’s Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons”, as such
terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act (other than the Corporation, any of its subsidiaries, an employee benefit plan maintained by the Corporation or any of its subsidiaries or a “person” that, prior to such
transaction, directly or indirectly controls, is controlled by, or is under common control with, the Corporation) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the
Corporation possessing more than 50% of the total combined voting power of the Corporation’s securities outstanding immediately after such acquisition; or 

(ii) During any period of two consecutive years, individuals who, at the beginning of such period, constitute the Board together with any new
director(s) (other than a director designated by a person who shall have entered into an agreement with the Corporation to 

 
effect a transaction described in Section 1(c)(i) or Section 1(c)(iii)) whose election by the Board or nomination for election by the Corporation’s stockholders was approved by a
vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a
majority thereof; or 
 (iii) The consummation by the Corporation (whether directly involving the Corporation or indirectly involving the
Corporation through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Corporation’s assets in any single
transaction or series of related transactions, in each case, other than a transaction: 
 (A) Which results in the
Corporation’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Corporation or the person that, as a result of the
transaction, controls, directly or indirectly, the Corporation or owns, directly or indirectly, all or substantially all of the Corporation’s assets or otherwise succeeds to the business of the Corporation (the Corporation or such person, the
“Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 

(B) After which no person or group beneficially owns voting securities representing 50% or more of the combined voting power
of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 1(c)(iii)(B) as beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting
power held in the Corporation prior to the consummation of the transaction. 
 (d) “COBRA” shall mean the Consolidated
Omnibus Budget Reconciliation Act of 1985, as amended. 
 (e) “COBRA Coverage” shall mean the coverage under the
Corporation’s medical, dental and/or vision benefit plans that Executive and/or Executive’s eligible dependents participates following a termination of employment pursuant to COBRA. 

(f) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(g) “Covered Termination” shall mean (i) an Involuntary Termination Without Cause or (ii) a voluntary termination
of employment by Executive for Good Reason, provided that in either case, the termination constitutes a Separation from Service. 
 (h)
“Date of Termination” shall mean (i) if Executive’s employment is terminated due to Executive’s death, the date of Executive’s death; and (ii) if Executive’s employment is terminated for any reason
other than death, the date specified in the Notice of Termination. 

  
 2 

 (i) “Employment Commencement Date” means the date Executive’s employment
commenced with the Corporation. 
 (j) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

(k) “First Payment Date” shall mean the 60th day after the Date of
Termination or, if such day is not a business day, the next business day thereafter. 
 (l) “Good Reason” shall mean
Executive’s resignation due to any of the following events which occurs without Executive’s written consent, provided that the requirements regarding advance notice and an opportunity to cure set forth below are satisfied: (i) a material
diminution of Executive’s base salary and target bonus, other than in connection with an across-the-board reduction in the compensation (which, for avoidance of doubt, may include the elimination of any bonus opportunity) of the Company’s
senior management that does not disproportionately affect Executive, (ii) a material diminution of Executive’s authority, duties or responsibilities, or (iii) a material change in the geographic location at which Executive must
perform services for the Corporation (each of (i), (ii) and (iii), a “Good Reason Condition”). In order for Executive to resign for Good Reason, Executive must provide written notice to the Corporation of the existence of the
Good Reason Condition within 90 days of the initial existence of such Good Reason Condition. Upon receipt of such notice of the Good Reason Condition, the Corporation will be provided with a period of 30 days during which it may remedy the Good
Reason Condition and not be required to provide for the payments and benefits described herein as a result of such proposed resignation due to the Good Reason Condition specified in the Notice of Termination. If the Good Reason Condition is not
remedied within the period specified in the preceding sentence, Executive may resign based on the Good Reason Condition specified in the Notice of Termination effective no later than 180 days following the initial existence of such Good Reason
Condition. 
 (m) “Involuntary Termination Without Cause” shall mean termination of Executive’s employment by the
Corporation other than for Cause. For purposes of this Agreement, an Involuntary Termination Without Cause shall only include a termination by the Corporation where the Executive was willing and able to continue performing services within the
meaning of Treasury Regulation Section 1.409A-1(n)(1). 
 (n) “Notice of Termination” shall mean a notice from
Executive or the Corporation to the other party regarding the intent to terminate Executive’s employment. To the extent applicable, the Notice of Termination shall indicate the specific termination provision in this Agreement (if any) relied
upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated. 

(o) “Release” shall mean a release by Executive of all claims arising out of Executive’s employment with the Corporation
or the termination thereof, in a form reasonably acceptable to the Corporation. 
 (p) “Separation from Service” means
Executive’s termination of employment or service which constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h). 

  
 3 

 2. Notice. 

(a) Notice of Termination. Any termination of Executive’s employment by the Corporation or by Executive (other than termination
due to Executive’s death, which shall terminate Executive’s employment automatically) shall be communicated by a written Notice of Termination to the other party hereto in accordance with Section 2(b) and shall set forth the Date of
Termination, which shall not be earlier than the date on which the Notice of Termination is provided. 
 (b) Manner of Notice. For
purposes of this Agreement, a Notice of Termination, as well as other notices and communications provided for in this Agreement, shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States certified or
registered mail, return receipt requested, postage prepaid, addressed to the Corporation at its principal office or to Executive at the address in the Corporation’s payroll records, provided that all notices to the Corporation shall be directed
to the attention of its Secretary, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

3. Compensation upon Certain Terminations. 

(a) Termination for Any Reason. Upon Executive’s termination of employment with the Corporation for any reason, Executive shall be
paid all amounts earned or accrued but unpaid as of the Executive’s termination of employment, including (i) base salary, (ii) reimbursement for reasonable and necessary expenses incurred by the Executive on behalf of the Corporation
during the period ending on the date of termination, (iii) pay for unused vacation time, (iv) any bonuses and incentive compensation earned through the date of termination, and (v) reimbursement for any unused amounts deposited in the
Corporation’s ESPP. 
 (b) Covered Termination Prior to a Change in Control or More Than Twelve Months After a Change in
Control. If Executive’s employment with the Corporation is terminated not less than six (6) months after the Employment Commencement Date due to a Covered Termination which occurs prior to a Change in Control or more than twelve
(12) months following a Change in Control, and Executive executes and does not revoke a Release as described in Section 3(d) below, then Executive shall be entitled to the following severance benefits: 

(i) Severance Payment. If the Date of Termination is less than one (1) year but not less than six (6) months after the
Employment Commencement Date, Executive shall be entitled to severance payments equal to three (3) months’ worth of the Executive’s then- current annual base salary (commencing as of the Date of Termination), and if the Date of
Termination is not less than one (1) year after the Employment Commencement Date, Executive shall be entitled to severance payments equal to six (6) months’ worth of the Executive’s then-current annual base salary (commencing as
of the Date of Termination). Severance payments 

  
 4 

 
shall be paid in accordance with the Corporation’s normal payroll procedures beginning on the First Payment Date, except that any payments that would otherwise have been made before the
First Payment Date shall be made on the First Payment Date. 
 (ii) Continued Benefits. If the Date of Termination is less than one
(1) year but not less than six (6) months after the Employment Commencement Date, the Corporation shall pay COBRA Coverage for Executive and Executive’s dependents for the period beginning on the Date of Termination and extending
through the earlier of either (A) three (3) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer, the
Corporation shall pay COBRA Coverage for Executive and Executive’s dependents. If the Date of Termination is not less than one (1) year after the Employment Commencement Date, the Corporation shall pay COBRA Coverage for Executive and
Executive’s dependents for the period beginning on the Date of Termination and extending through the earlier of either (A) three (3) months from the Date of Termination, or (B) the first day of Executive’s eligibility to
participate in a comparable group health plan maintained by a subsequent employer, the Corporation shall pay COBRA Coverage for Executive and Executive’s dependents. 

(c) Covered Termination Within Twelve Months After a Change in Control. If Executive’s employment with the Corporation is
terminated due to a Covered Termination which occurs within twelve (12) months following a Change in Control, and Executive executes and does not revoke a Release as described in Section 3(d) below, then Executive shall be entitled to the
following severance benefits: 
 (i) Acceleration of Equity Awards. Executive shall become vested with respect to one hundred
percent (100%) of the unvested portion of any options to purchase the Corporation’s capital stock that Executive then holds and the restrictions with respect to one hundred percent (100%) of any restricted share award, restricted
stock unit award or other equity award with regard to the Corporations’ capital stock that Executive then holds shall immediately lapse. 

(ii) Severance Payment. Executive shall be entitled to severance payments equal to six (6) months worth of the Executive’s
then-current annual base salary (commencing as of the Date of Termination) and a pro rated portion of Executive’s annual target bonus for the same period, which payments shall be paid in accordance with the Corporation’s normal payroll
procedures beginning on the First Payment Date, except that any payments that would otherwise have been made before the First Payment Date shall be made on the First Payment Date. 

(iii) Continued Benefits. For the period beginning on the Date of Termination and extending through the earlier of either
(A) six (6) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer, the Corporation shall pay COBRA Coverage for
Executive and Executive’s dependents. 

  
 5 

 (d) Release. As a condition to Executive’s receipt of any benefits described in this
Section 3 (other than in Section 3(a)), Executive shall be required to execute a Release within fifty (50) days following the Date of Termination and not revoke such Release within any period permitted under applicable law. Such
Release shall specifically relate to all of Executive’s rights and claims in existence at the time of such execution but shall exclude any continuing obligations the Corporation may have to Executive following the date of termination under this
Agreement or any other agreement providing for obligations to survive Executive’s termination of employment. 
 4.
Section 409A. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Corporation at the time of his Separation from Service to be a “specified employee” for purposes of
Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under
Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (a) the expiration of the six-month period measured from the date of Executive’s Separation
from Service or (b) the date of Executive’s death. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 4 shall be paid in a
lump sum to Executive, and any remaining payments due under the Agreement shall be paid as otherwise provided herein. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation
Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments payable hereunder shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times
be considered a separate and distinct payment. 
 5. Excise Tax Limitation. 

(a) Notwithstanding anything contained in this Agreement to the contrary, in the event that the benefits provided by this Agreement, together
with all other payments and the value of any benefits received or to be received by Executive (“Payments”), constitute “parachute payments” within the meaning of Section 280G of the Code, and, but for this
Section 5, would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payments shall be made to Executive either (i) in full or (ii) as to such lesser amount as would
result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an
after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of the Payments may be subject to the Excise Tax. The Corporation shall reduce or eliminate the Payments by first reducing or eliminating cash payments and
then by reducing those payments or benefits which are not payable in cash, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the Determination (as hereinafter defined). 

(b) Unless the Corporation and Executive otherwise agree in writing, an initial determination as to whether the Payments shall be reduced and
the amount of such reduction shall be made, at the Corporation’s expense, by the accounting firm that is the Corporation’s independent accounting firm as of the date of the Change in Control (the “Accounting Firm”). The
Accounting Firm shall provide its determination (the “Determination”), together with 

  
 6 

 
detailed supporting calculations and documentation, to the Corporation and Executive within twenty (20) days of the Date of Termination if applicable, or such other time as requested by the
Corporation or by Executive (provided Executive reasonably believes that Executive will receive Payments which may be subject to the Excise Tax), and if the Accounting Firm determines that there is substantial authority (within the meaning of
Section 6662 of the Code) that no Excise Tax is payable by Executive with respect to a Payment or Payments, it shall furnish Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to any
such Payment or Payments. Within ten (10) days of the delivery of the Determination to Executive, Executive shall have the right to dispute the Determination (the “Dispute”). If there is no Dispute, the Determination shall be
binding, final and conclusive upon the Corporation and Executive. 
 (c) As a result of the uncertainty in the application of Sections 4999
and 280G of the Code, it is possible that the Payments to be made to, or provided for the benefit of, Executive either will be greater (an “Excess Payment”) or less (an “Underpayment”) than the amounts provided for
by the limitation contained in Section 5(a). 
 (i) If it is established pursuant to a final determination of a court or an Internal
Revenue Service (the “IRS”) proceeding which has been finally and conclusively resolved that an Excess Payment has been made, such Excess Payment shall be deemed for all purposes to be a loan to Executive made on the date Executive
received the Excess Payment and Executive shall repay the Excess Payment to the Corporation on demand (but not less than ten (10) days after written notice is received by Executive) together with interest on the Excess Payment at the
“Applicable Federal Rate” (as defined in Section 1274(d) of the Code) from the date of Executive’s receipt of such Excess Payment until the date of such repayment. 

(ii) In the event that it is determined by (A) the Accounting Firm, the Corporation (which shall include the position taken by the
Corporation, or together with its consolidated group, on its federal income tax return) or the IRS, (B) pursuant to a determination by a court, or (C) upon the resolution to Executive’s satisfaction of the Dispute that an Underpayment
has occurred, the Corporation shall pay an amount equal to the Underpayment to Executive within ten (10) days of such determination or resolution, together with interest on such amount at the Applicable Federal Rate from the date such amount
would have been paid to Executive until the date of payment. 
 6. Successors; Binding Agreement. 

(a) The Corporation shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Corporation to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation would be required to perform it if no such succession had taken
place. Unless expressly provided otherwise, “Corporation” as used herein shall mean the Corporation as defined in this Agreement and any successor to its business and/or assets as aforesaid. 

(b) This Agreement shall inure to the benefit of and be enforceable by Executive and Executive’s personal or legal representatives,
executors, administrators, 

  
 7 

 
successors, heirs, distributees, devisees and legatees. If Executive should die while any amount would still be payable to Executive hereunder had Executive continued to live, all such amounts,
unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee or other designee or, if there is no such designee, to Executive’s estate. 

7. Miscellaneous. 
 (a)
Modification or Amendment. No provision of this Agreement may be modified or amended unless such modification or amendment is agreed to in writing and signed by Executive and an authorized officer of the Corporation as may be specifically
designated by the Board or a committee thereof. 
 (b) Waiver. No waiver by either party hereto at any time of any breach by the
other party hereto of or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.

 (c) Complete Agreement. This Agreement constitutes the entire agreement between Executive and the Corporation and is the complete,
final and exclusive embodiment of their agreement with regard to this subject matter, and this Agreement shall supersede any prior or contemporaneous written or oral agreements regarding this subject matter. No agreements or representations, oral or
otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly set forth in this Agreement. 

(d) Non-Exclusivity of Rights. Notwithstanding Section 7(c), nothing in this Agreement shall prevent or limit Executive’s
continuing or future participation in any benefit, bonus, incentive or other plan or program provided by the Corporation (except for any severance or termination policies, plans, programs or practices) and for which Executive may qualify, nor shall
anything herein limit or reduce such rights as Executive may have under any other agreements with the Corporation (except for any severance, termination or other agreement regarding the subject matter of this Agreement). Amounts which are vested
benefits or which Executive is otherwise entitled to receive under any plan or program of the Corporation shall be payable in accordance with such plan or program, except as explicitly modified by this Agreement. 

(e) Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the
State of California without regard to its conflicts of law principles. 
 (f) Statutory References. All references to sections of the
Exchange Act or the Code shall be deemed also to refer to any successor provisions to such sections. 
 (g) Tax Withholding. Any
payments provided for hereunder shall be paid net of any applicable withholding required under federal, state or local law. 
 (h)
Section Headings. The section headings contained in this Agreement are for convenience only, and shall not affect the interpretation of this Agreement. 

  
 8 

 (i) Severability. The invalidity or unenforceability of any provision of this Agreement
shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

(j) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of
which together shall constitute one and the same instrument, 
 8. Arbitration. The parties hereby agree that any and all claims or
controversies regarding this Agreement shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in Palo Alto, California conducted before a single arbitrator by Judicial Arbitration and Mediation
Services/Endispute (“JAMS”) or its successor, under the then applicable JAMS rules. By agreeing to this arbitration procedure, both parties waive the right to resolve any such dispute through a trial by jury or judge or by
administrative proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration
decision including the arbitrator’s essential findings and conclusions and a statement of the award. The Corporation shall pay all of JAMS’ arbitration fees. Nothing in this Agreement shall prevent either party from obtaining injunctive
relief in court if necessary to prevent irreparable harm pending the conclusion of any arbitration. 
 9. Fees and Expenses. In
connection with a Covered Termination which occurs within twelve (12) months after a Change in Control, the Corporation shall pay all reasonable legal fees and related expenses (including the costs of experts, evidence and counsel) incurred by
Executive as they become due as a result of (a) Executive seeking to obtain or enforce any right or benefit provided by this Agreement (including, but not limited to, any such fees and expenses incurred in connection with the Dispute whether as
a result of any applicable government taxing authority proceeding, audit or otherwise), and (b) Executive’s hearing before the Board as contemplated in Section 1(b) of this Agreement. To the extent that any reimbursements payable to
Executive pursuant to this Section 9 are subject to the provisions of Section 409A of the Code, such reimbursements shall be paid to Executive no later than December 31 of the year following the year in which the cost was incurred,
the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Section 9 will not be subject to liquidation or exchange for
another benefit. 
 10. Settlement of Claims. The Corporation’s obligation to make the payments provided for in this Agreement
and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which the Corporation may have against Executive or others.

 11. At-Will Employment. Nothing contained in this Agreement shall (a) confer upon Executive any right to continue in the
employ of the Corporation, (b) constitute any contract or agreement of employment, or (c) interfere in any way with the at-will nature of Executive’s employment with the Corporation. 

  
 9 

 12. Miscellaneous. The Corporation shall not be required to fund or otherwise segregate
assets to be used for the payment of any benefits under this Agreement. The Corporation shall make such payments only out of its general corporate funds, and therefore its obligation to make such payments shall be subject to any claims of its other
creditors having priority as to its assets. 
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date. 

 

			
	EXECUTIVE
	
	

 1/12/2013
	  

	Robert O. Cathcart
	
	HANSEN MEDICAL, INC.
	
	

	  

		
	By:	 	Bruce J Barclay
		 	President and CEO

  
 10EX-10.46

 Exhibit 10.46 

HANSEN MEDICAL, INC. 

SECOND AMENDMENT TO OFFICE LEASE 

This SECOND AMENDMENT TO OFFICE LEASE, (the “Second Amendment”) is made and entered into as of December 18, 2013
by and between BXP RESEARCH PARK LP, a Delaware limited partnership, formerly known as BXP RESEARCH PARK LLC, a Delaware limited liability company, and successor-in-interest to MTV RESEARCH, LLC, a Delaware liability company
(“Landlord”), and HANSEN MEDICAL, INC., a Delaware corporation (“Tenant”). 
 R E C I T A L S: 

 

	A.	Landlord and Tenant are parties to that certain Office Lease dated July 18, 2007, and as amended by that First Amendment to Office Lease dated June 27, 2008 (collectively, the “Original
Lease”), whereby Landlord leases to Tenant and Tenant leases from Landlord approximately 63,131 rentable square feet of office space (the “Premises”), located at 800 East Middlefield Road in Mountain View, California 94043
(the “Building”), which Building is owned by Landlord. 

  

	B.	Landlord and Tenant desire to (i) extend the term of the Original Lease for the Premises for a period of five (5) years and (ii) make certain other modifications to the Original Lease, and in connection
therewith Landlord and Tenant desire to amend the Original Lease on the terms and conditions contained herein. 

 A G R E E M E
N T: 
 NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows. 
 1.
Defined Terms. All capitalized terms not otherwise defined herein shall have the same meaning as is given such terms in the Original Lease. From and after the date hereof, all references in the Original Lease and herein to the
“Lease” shall mean and refer to the Original Lease as amended hereby. 
 2. Extended Term. Landlord and Tenant
acknowledge and agree that the Lease Term for the Premises is scheduled to expire on November 30, 2014 (the “Scheduled Expiration Date”) pursuant to the terms of the Original Lease. Notwithstanding anything to the contrary in
the Lease, the term of Tenant’s lease of the Premises shall expire on November 30, 2020 (the “Extended Term Expiration Date”), unless sooner terminated in the Lease. The period of time commencing on December 1, 2014
(the “Extended Term Commencement Date”) and terminating on the Extended Term Expiration Date shall be referred to as the “Extended Term.” Effective upon the Extended Term Commencement Date, all references in the
Lease to the “Lease Term” shall mean and refer to the Extended Term, and all references to the “Lease Expiration Date” shall mean and refer to the “Extended Term Expiration Date.” 

  

					
		 	  
 Page 1
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 3. Base Rent. 

3.1 Base Rent. Commencing on the Extended Term Commencement Date, and continuing throughout the Extended Term, Tenant shall pay
Base Rent for the Premises in accordance with the following schedule: 
  

									
	 Period During Extended Term
	  	Annual Base Rent	 	  	Monthly Installment of
Base Rent	 
	 December 1, 2014 – November 30, 2015
	  	$	2,083,323.00	  	  	$	173,610.25	  
	 December 1, 2015 – November 30, 2016
	  	$	2,145,822.69	  	  	$	178,818.56	  
	 December 1, 2016 – November 30, 2017
	  	$	2,210,197.37	  	  	$	184,183.11	  
	 December 1, 2017 – November 30, 2018
	  	$	2,276,503.29	  	  	$	189,708.61	  
	 December 1, 2018 – November 30, 2019
	  	$	2,344,798.39	  	  	$	195,399.87	  

 3.2 Abated Base Rent. Provided that Tenant is not then in default of the Lease, then during the
last two (2) full calendar months of the Extended Term (the “Rent Abatement Period”), Tenant shall not be obligated to pay any Base Rent otherwise attributable to the Premises during such Rent Abatement Period (the
“Rent Abatement”). Landlord and Tenant acknowledge that the aggregate amount of the Rent Abatement equals Three Hundred Ninety Thousand Seven Hundred Ninety-Nine and 74/100 Dollars ($390,799.74). Tenant acknowledges and agrees that
the foregoing Rent Abatement has been granted to Tenant as additional consideration for entering into this Second Amendment, and for agreeing to pay the rental and performing the terms and conditions otherwise required under the Lease. If Tenant
shall be in default under the Lease during the Rent Abatement Period and shall fail to cure such default within the notice and cure period, if any, permitted for cure pursuant to the Lease, then the Rent Abatement as of the date of such default
shall terminate effective immediately and Tenant shall immediately be obligated to recommence paying Base Rent for the Premises in full and Tenant shall have no further right to any Rent Abatement hereunder. 

4. Option to Renew. Article 50 of the Original Lease is hereby deleted in its entirety and replaced with the
following: 
 50. Option Term. 

50.1 Option Right. Landlord hereby grants to the originally named Tenant herein (“Original Tenant”) one
(1) option to extend the Lease Term for a period of five (5) years (the “Option Term”), which option shall be irrevocably exercised only by written notice delivered by Tenant to Landlord by March 1, 2019, provided
that the following conditions (the “Option Conditions”) are satisfied: (i) as of the date of delivery of such notice, Tenant is not in default under this Lease; (ii) as of the end of the Lease Term, Tenant is not in
default under this Lease; (iii) Tenant has not previously been in monetary or material non-monetary default under 

  

					
		 	  
 Page 2
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 
this Lease more than once; and (iv) the Lease then remains in full force and effect and Original Tenant occupies the entire Premises at the time the option to extend is exercised and as of
the commencement of the Option Term. Landlord may, at Landlord’s option, exercised in Landlord’s sole and absolute discretion, waive any of the Option Conditions in which case the option, if otherwise properly exercised by Tenant, shall
remain in full force and effect. Upon the proper exercise of such option to extend, and provided that Tenant satisfies all of the Option Conditions (except those, if any, which are waived by Landlord), the Lease Term, as it applies to the Premises,
shall be extended for a period of five (5) years. The rights contained in this Section 50.1 shall be personal to Original Tenant and any Approved Assignee (as defined in Article 34) and may be exercised by Original Tenant or an
Approved Assignee only. 
 50.2 Option Rent. The annual Rent payable by Tenant during the Option Term (the “Option
Rent”) shall be equal to the “Fair Rental Value,” as that term is defined below, for the Premises as of the commencement date of the Option Term. The “Fair Rental Value,” as used in this Lease, shall be
equal to the annual rent per rentable square foot (including additional rent and considering any “base year” or “expense stop” applicable thereto), including all escalations, at which tenants (pursuant to leases consummated
within the twelve (12) month period preceding the first day of the Option Term), are leasing non-sublease, non-encumbered, non-equity space which is not significantly greater or smaller in size than the subject space, for a comparable lease
term, in an arm’s length transaction, which comparable space is located in the “Comparable Buildings,” as that term is defined in this Section 50.2, below (transactions satisfying the foregoing criteria shall be known as
the “Comparable Transactions”), taking into consideration the following concessions (the “Concessions”): (a) rental abatement concessions, if any, being granted such tenants in connection with such comparable
space; (b) tenant improvements or allowances provided or to be provided for such comparable space, and taking into account the value, if any, of the existing improvements in the subject space, such value to be based upon the age, condition,
design, quality of finishes and layout of the improvements and the extent to which the same can be utilized by a general office user other than Tenant; and (c) other reasonable monetary concessions being granted such tenants in connection with
such comparable space; provided, however, that in calculating the Fair Rental Value, no consideration shall be given to (i) the fact that Landlord is or is not required to pay a real estate brokerage commission in connection with Tenant’s
exercise of its right to extend the Lease Term, or the fact that landlords are or are not paying real estate brokerage commissions in connection with such comparable space, and (ii) any period of rental abatement, if any, granted to tenants in
comparable transactions in connection with the design, permitting and construction of tenant improvements in such comparable spaces. The Fair Rental Value shall additionally include a determination as to whether, and if so to what extent, Tenant
must provide Landlord with financial security, such as a letter of credit or guaranty, for Tenant’s Rent obligations in connection with Tenant’s lease of the Premises during the Option Term. Such determination shall be made by reviewing
the extent of financial security then generally being imposed in Comparable Transactions from tenants of comparable financial condition and credit history to the then existing financial condition and credit history of Tenant (with appropriate
adjustments to account for differences in the then-existing financial condition of Tenant and such other tenants). The Concessions (A) shall be reflected in the effective rental rate (which effective rental rate shall take into consideration
the total dollar value of such Concessions as amortized on a 

  

					
		 	  
 Page 3
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 
straight-line basis over the applicable term of the Comparable Transaction (in which case such Concessions evidenced in the effective rental rate shall not be granted to Tenant)) payable by
Tenant, or (B) at Landlord’s election, all such Concessions shall be granted to Tenant in kind. The term “Comparable Buildings” shall mean the buildings in the Project and other office and research and development
buildings which are located within a 5 mile radius (the “Comparable Area”). 
 50.3 Determination of Option
Rent. In the event Tenant timely and appropriately exercises an option to extend the Lease Term, Landlord shall notify Tenant of Landlord’s determination of the Option Rent on or before the date that is six (6) months prior to the
Lease Expiration Date. If Tenant, on or before the date which is thirty (30) days following the date upon which Tenant receives Landlord’s determination of the Option Rent, in good faith objects to Landlord’s determination of the
Option Rent, then Landlord and Tenant shall attempt to agree upon the Option Rent using their best good-faith efforts. If Landlord and Tenant fail to reach agreement within thirty (30) days following Tenant’s objection to the Option Rent
(the “Outside Agreement Date”), then each party shall make a separate determination of the Option Rent, as the case may be, within five (5) days, and such determinations shall be submitted to arbitration in accordance with
Sections 50.3.1 through 50.3.8, below. 
 50.3.1 Landlord and Tenant shall each appoint one arbitrator who shall be, at the
option of the appointing party, a real estate broker, appraiser or attorney who shall have been active over the five (5) year period ending on the date of such appointment in the leasing or appraisal, as the case may be, of commercial
properties in the Comparable Area. The determination of the arbitrators shall be limited solely to the issue of whether Landlord’s or Tenant’s submitted Option Rent is the closest to the actual Option Rent, taking into account the
requirements of Section 50.2 of this Lease, as determined by the arbitrators. Each such arbitrator shall be appointed within fifteen (15) days after the Outside Agreement Date. Landlord and Tenant may consult with their selected
arbitrators prior to appointment and may select an arbitrator who is favorable to their respective positions. The arbitrators so selected by Landlord and Tenant shall be deemed “Advocate Arbitrators.” 

50.3.2 The two (2) Advocate Arbitrators so appointed shall be specifically required pursuant to an engagement letter within ten
(10) days of the date of the appointment of the last appointed Advocate Arbitrator to agree upon and appoint a third arbitrator (“Neutral Arbitrator”) who shall be qualified under the same criteria set forth hereinabove for
qualification of the two Advocate Arbitrators, except that neither the Landlord or Tenant or either parties’ Advocate Arbitrator may, directly or indirectly, consult with the Neutral Arbitrator prior or subsequent to his or her appearance. The
Neutral Arbitrator shall be retained via an engagement letter jointly prepared by Landlord’s counsel and Tenant’s counsel. 

50.3.3 The three arbitrators shall, within thirty (30) days of the appointment of the Neutral Arbitrator, reach a decision as to whether
the parties shall use Landlord’s or Tenant’s submitted Option Rent, and shall notify Landlord and Tenant thereof. 
 50.3.4 The
decision of the majority of the three arbitrators shall be binding upon Landlord and Tenant. 

  

					
		 	  
 Page 4
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 50.3.5 If either Landlord or Tenant fails to appoint an Advocate Arbitrator within fifteen
(15) days after the Outside Agreement Date, then either party may petition the presiding judge of the Superior Court of Santa Clara County to appoint such Advocate Arbitrator subject to the criteria in Section 50.3.1 of this Lease,
or if he or she refuses to act, either party may petition any judge having jurisdiction over the parties to appoint such Advocate Arbitrator. 

50.3.6 If the two (2) Advocate Arbitrators fail to agree upon and appoint the Neutral Arbitrator, then either party may petition the
presiding judge of the Superior Court of Santa Clara County to appoint the Neutral Arbitrator, subject to criteria in Section 50.3.2 of this Lease, or if he or she refuses to act, either party may petition any judge having jurisdiction
over the parties to appoint such arbitrator. 
 50.3.7 The cost of the arbitration shall be paid by Landlord and Tenant equally. 

50.3.8 In the event that the Option Rent shall not have been determined pursuant to the terms hereof prior to the commencement of the Option
Term, Tenant shall be required to pay the Option Rent initially provided by Landlord to Tenant, and upon the final determination of the Option Rent, the payments made by Tenant shall be reconciled with the actual amounts of Option Rent due, and the
appropriate party shall make any corresponding payment to the other party. 
 5. Possession of Premises; Renovations.

 (a) Possession of Premises. Tenant hereby acknowledges and agrees that it is currently in possession of the Premises, and that
Landlord has no obligation to alter, modify, remodel or otherwise improve the Premises, it being agreed between Landlord and Tenant that Tenant shall accept the Premises in its current “AS-IS “WHERE-IS” condition, without
representation or warranty from Landlord other than already provided in the Original Lease. 
 (b) Tenant’s Intended Renovations;
Landlord’s Contribution. Notwithstanding the foregoing, Landlord acknowledges that Tenant intends to refurbish the Premises, including, without limitation, modifications of interior improvements (collectively, “Tenant’s
Intended Renovations”). Tenant acknowledges that Tenant’s Intended Renovations shall be subject to Landlord’s approval and all requirements contained in the Lease, including without limitation, Article 12 of the Original Lease,
and shall be at Tenant’s sole cost and expense; provided, however, that Landlord shall, as an improvement contribution (“Landlord’s Contribution”), provide up to a maximum amount of One Hundred Eight Nine Thousand Three
Hundred Ninety-Three and No/100 Dollars ($189,393.00) or Three Dollars and No/100 Dollars ($3.00) per rentable square foot of the Premises (the “Renovation Allowance Maximum Amount”). Landlord’s Contribution shall be payable
only upon satisfaction of all of the following conditions precedent: (i) the satisfactory completion of Tenant’s Intended Renovations, (ii) Tenant’s submission to Landlord of California statutory forms of unconditional waiver and
release of lien upon final payment executed by, as applicable, the general contractor, all subcontractors performing any portion of Tenant’s Intended Renovations and all suppliers or materialmen

  

					
		 	  
 Page 5
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 
supplying any materials for Tenant’s Intended Renovations and (iii) proof of Tenant’s payment of all costs incurred in connection with Tenant’s Intended Renovation.
Landlord’s Contribution shall be used only for costs relating to permanent improvements to the Premises (collectively, “Allowable Costs”), excluding the cost of furniture, fixtures and equipment installed in the Premises by
Tenant. Tenant hereby acknowledges and agrees that it will complete Tenant’s Intended Renovations not later than twelve (12) months after the Extended Term Commencement Date. In the event that the Tenant Improvement Allowance is not fully
disbursed by Landlord to, or on behalf of, Tenant on or before the date that is twelve (12) months after the Extended Term Commencement Date, then such unused amounts shall revert to Landlord, and Tenant shall have no further rights with
respect thereto. Upon request by Tenant at the time of Tenant’s request for Landlord’s consent to any Tenant’s Intended Renovations, Landlord shall notify Tenant whether the applicable Tenant’s Intended Renovation will be
required to be removed in accordance with Article 12 of the Lease. 
 6. Disclosure. Pursuant to California Civil Code
Section 1938, Landlord hereby notifies Tenant that as of the date of this Second Amendment, the Premises has not undergone inspection by a “Certified Access Specialist” to determine whether the Premises meet all applicable
construction-related accessibility standards under California Civil Code Section 55.53. 
 7. Brokers. Landlord and
Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent other than Jones Lang LaSalle (“Tenant’s Broker”) or Cassidy Turley Northern California (“Landlord’s
Broker”) (collectively, “Brokers”) in connection with the negotiation of this Second Amendment and that they know of no real estate broker or agent, other than Brokers, who are entitled to a commission in connection with this
Second Amendment. Each party agrees to indemnify and defend the other party against and hold the other party harmless from any and all claims, demands, losses, liabilities, lawsuits, judgments, and costs and expenses (including, without limitation,
reasonable attorneys’ fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or agent, other than Brokers, occurring by, through, or under the
indemnifying party. The terms of this Paragraph 7 shall survive the expiration or earlier termination of this Second Amendment. 
 9.
No Further Modification. Except as specifically set forth in this Second Amendment, all of the terms and provisions of the Lease shall remain unmodified and in full force and effect. In the event of any conflict between the terms and
conditions of the Lease, and the terms and conditions of this Second Amendment, the terms and conditions of this Second Amendment shall prevail. 

[REMAINDER OF PAGE LEFT BLANK INTENTIONALLY] 

  

					
		 	  
 Page 6
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

 IN WITNESS WHEREOF, this Second Amendment has been executed as of the day and year first above
written. 

 

					
	TENANT:
	
	HANSEN MEDICAL, INC., a Delaware corporation
		
	BY:	 	

		 	  

			
		 	Name:	 	 Bruce J Barclay

			
		 	Its:	 	 CEO

		
	BY:	 	

		 	  

			
		 	Name:	 	 Peter J. Mariani

			
		 	Its:	 	 CFO

  
 

 

									
	LANDLORD:
	
	 BXP RESEARCH PARK LLC,
 a
Delaware limited liability company

		
	BY:	 	BOSTON PROPERTIES
		 	LIMITED PARTNERSHIP,
		 	 a Delaware limited partnership,
 its
manager

			
		 	BY:	 	 BOSTON PROPERTIES, INC.,
 a Delaware
corporation,
 its general partner

				
		 		 	BY:	 	

		 		 		 	  

									
		 		 		 	  Name:	 	Bob Pester
		 		 		 	  Title:	 	Senior Vice President and Regional Manager

 
 

  

					
		 	  
 Page 7
	 	 MOUNTAIN VIEW RESEARCH PARK

Hansen Medical

SF/Legal

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]